The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a rare, chronic, and progressive interstitial lung disease with an average survival of approximately 3 years. The evolution of IPF is unpredictable, with some patients presenting a relatively stable condition with limited progression over time, whereas others d...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Philomène Lavis, Ani Garabet, Alessandra Kupper Cardozo, Benjamin Bondue
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	FAP fibroblast activation protein FAPI PPF IPF progression
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1393778/full